“Bringing truly innovative new drugs to market is protracted, expensive and fraught with uncertainty. Combining efforts to help improve the chances of success, to the benefit of patients and society is what attracted me to CASMI”
Aroon Hingorani is Director of the UCL Institute of Cardiovascular Science and Professor of Genetic Epidemiology.
He graduated in Physiological Sciences from the University of Oxford in in 1986, and in Medicine, from the United Medical and Dental Schools (Guy’s Hospital) in 1989. After clinical posts in London, he undertook research on the genetics of high blood pressure as an MRC Clinical Training Fellow in the University of Cambridge, obtaining his PhD in 1993. He continued specialist training in General Medicine and Clinical Pharmacology at UCL and UCL Hospitals, pursuing research on endothelial function in cardiovascular disease and then cardiovascular genomics, as a BHF Intermediate and then Senior Fellow.
His current work focuses on the use of genetic studies in populations as a tool to identify and validate drug targets, using the Mendelian randomisation principle.